FTC Warns 24 Major Hospital Systems on Deceptive Pricing
The FTC sent letters to 24 large healthcare companies warning that opaque or inaccurate pricing disclosures may constitute unfair or deceptive practices.
The Federal Trade Commission put 24 of the country's largest healthcare services companies on notice this week, warning that failures to disclose accurate and complete pricing information to patients could expose them to legal liability under federal consumer protection law.
FTC Chairman Andrew N. Ferguson signed the letters personally, underscoring the agency's position that hospitals and health systems have a clear legal obligation to furnish timely, accurate, and complete pricing data before patients receive care. The move signals heightened regulatory scrutiny of how major providers communicate costs to consumers.
Read more Fed Extends Regulation O Comment Period to November 4 →
Hospital price transparency has been a persistent flashpoint in U.S. healthcare policy. Federal rules requiring hospitals to post machine-readable price files and consumer-friendly displays have been on the books for several years, yet compliance has remained inconsistent across the industry. The FTC's intervention suggests the commission views inadequate disclosure not merely as a regulatory oversight matter but potentially as a deceptive trade practice subject to its own enforcement authority.
The letters function as a formal warning rather than an immediate enforcement action, but the distinction may be short-lived. By framing opaque pricing as potentially unfair or deceptive, the FTC is laying groundwork that could support future investigations or civil actions against non-compliant providers. Healthcare systems that ignore the letters risk drawing direct FTC scrutiny at a time when the agency has signaled it intends to take an aggressive posture toward industry practices that harm consumers.
Continue reading at Press Release Feed.
